Zonisamide 400 mg enhances weight loss for obese
(HealthDay)—A prescription medication originally developed to treat epilepsy may help obese adults shed weight when combined with routine nutritional counseling, researchers say.
Oct 16, 2012
0
3
(HealthDay)—A prescription medication originally developed to treat epilepsy may help obese adults shed weight when combined with routine nutritional counseling, researchers say.
Oct 16, 2012
0
3
Just like the old Crystal Gayle song, a new laser technology could soon allow you to turn those boring brown eyes of your to a rich and beautiful blue. But you better make sure that blue eyes are what you really want because ...
(Medical Xpress) -- Yale researcher Jose Cordova and Erich Astudillo from the University of Chile (and Founder of Top Tech Innovations SpA) have after working together, discovered a new molecule that kills the bacteria Streptococcus ...
A St. Michael's retinal surgeon and researcher has developed a new, minimally-invasive technique to repair retinal detachment that requires no incisions and can be done in the ophthalmologist's office. It could lead to faster ...
Aug 25, 2023
0
847
In Alzheimer's disease, the degeneration of brain cells is linked to formation of toxic protein aggregates and deposits known as amyloid plaques. Similar processes also play an important role in type 2 diabetes. A research ...
Nov 9, 2022
0
1142
A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.
May 23, 2016
1
57
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire ...
Mar 26, 2013
15
0
The U.S. Supreme Court on Thursday unanimously threw out attempts to patent human genes, siding with advocates who say the multibillion-dollar biotechnology industry should not have exclusive control over genetic information ...
Jun 13, 2013
31
0
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published in the journal Science Advances.
Dec 8, 2023
0
237
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed probiotics with a unique edible coating that ensures the beneficial bacteria successfully reach the intestine once they are ingested.
Mar 25, 2022
0
96
A patent ( /ˈpætənt/ or /ˈpeɪtənt/) is a form of intellectual property. It consists of a set of exclusive rights granted by a sovereign state to an inventor or their assignee for a limited period of time in exchange for the public disclosure of an invention.
The procedure for granting patents, the requirements placed on the patentee, and the extent of the exclusive rights vary widely between countries according to national laws and international agreements. Typically, however, a patent application must include one or more claims defining the invention which must meet the relevant patentability requirements such as novelty and non-obviousness. The exclusive right granted to a patentee in most countries is the right to prevent others from making, using, selling, or distributing the patented invention without permission.
Under the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights, patents should be available in WTO member states for any inventions, in all fields of technology, and the term of protection available should be a minimum of twenty years. In many countries, certain subject areas are excluded from patents, such as business methods and computer programs.
This text uses material from Wikipedia, licensed under CC BY-SA